カテゴリー： Market Monitor Global, 世界, 医療/バイオ

帯状疱疹治療薬の世界市場見通し2023年-2029年

◆英語タイトル：Herpes Zoste Drug Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5615）◆商品コード：MMG23JU5615
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月
◆ページ数：76
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Herpes Zoste Drug Market 調査レポートは次の情報を含め、グローバルにおけるの帯状疱疹治療薬市場規模と予測を収録しています。・世界の帯状疱疹治療薬市場：売上、2018年-2023年、2024年-2029年
・世界の帯状疱疹治療薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の帯状疱疹治療薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「アシクロビル」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

帯状疱疹治療薬のグローバル主要企業は、Astellas Pharma Inc.、 Beijing Minhai Biotechnology Co., Ltd、 ContraVir Pharmaceuticals, Inc.、 Epiphany Biosciences, Inc.、 Foamix Pharmaceuticals Ltd.、 GeneOne Life Science, Inc.、 GlaxoSmithKline Plc、 Merck & Co., Inc.、 NAL Pharmaceuticals Ltd.、 ReceptoPharm, Inc.、 TSRL, Inc.などです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、帯状疱疹治療薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の帯状疱疹治療薬市場：タイプ別、2018年-2023年、2024年-2029年
世界の帯状疱疹治療薬市場：タイプ別市場シェア、2022年
・アシクロビル、アメナメビル、FV-100、GLS-5100、GSK-1437173A、NAL-3221、その他

世界の帯状疱疹治療薬市場：用途別、2018年-2023年、2024年-2029年
世界の帯状疱疹治療薬市場：用途別市場シェア、2022年
・クリニック、病院、その他

世界の帯状疱疹治療薬市場：地域・国別、2018年-2023年、2024年-2029年
世界の帯状疱疹治療薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における帯状疱疹治療薬のグローバル売上、2018年-2023年
・主要企業における帯状疱疹治療薬のグローバル売上シェア、2022年
・主要企業における帯状疱疹治療薬のグローバル販売量、2018年-2023年
・主要企業における帯状疱疹治療薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Astellas Pharma Inc.、 Beijing Minhai Biotechnology Co., Ltd、 ContraVir Pharmaceuticals, Inc.、 Epiphany Biosciences, Inc.、 Foamix Pharmaceuticals Ltd.、 GeneOne Life Science, Inc.、 GlaxoSmithKline Plc、 Merck & Co., Inc.、 NAL Pharmaceuticals Ltd.、 ReceptoPharm, Inc.、 TSRL, Inc.

*************************************************************

・調査・分析レポートの概要
帯状疱疹治療薬市場の定義
市場セグメント
世界の帯状疱疹治療薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の帯状疱疹治療薬市場規模
世界の帯状疱疹治療薬市場規模：2022年 VS 2029年
世界の帯状疱疹治療薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの帯状疱疹治療薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の帯状疱疹治療薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：アシクロビル、アメナメビル、FV-100、GLS-5100、GSK-1437173A、NAL-3221、その他
帯状疱疹治療薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：クリニック、病院、その他
帯状疱疹治療薬の用途別グローバル売上・予測

・地域別市場分析
地域別帯状疱疹治療薬市場規模 2022年と2029年
地域別帯状疱疹治療薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Astellas Pharma Inc.、 Beijing Minhai Biotechnology Co., Ltd、 ContraVir Pharmaceuticals, Inc.、 Epiphany Biosciences, Inc.、 Foamix Pharmaceuticals Ltd.、 GeneOne Life Science, Inc.、 GlaxoSmithKline Plc、 Merck & Co., Inc.、 NAL Pharmaceuticals Ltd.、 ReceptoPharm, Inc.、 TSRL, Inc.
...

This report aims to provide a comprehensive presentation of the global market for Herpes Zoste Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Herpes Zoste Drug. This report contains market size and forecasts of Herpes Zoste Drug in global, including the following market information:
Global Herpes Zoste Drug Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Herpes Zoste Drug Market Sales, 2018-2023, 2024-2029, (K Pcs)
Global top five Herpes Zoste Drug companies in 2022 (%)
The global Herpes Zoste Drug market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Acyclovir Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Herpes Zoste Drug include Astellas Pharma Inc., Beijing Minhai Biotechnology Co., Ltd, ContraVir Pharmaceuticals, Inc., Epiphany Biosciences, Inc., Foamix Pharmaceuticals Ltd., GeneOne Life Science, Inc., GlaxoSmithKline Plc, Merck & Co., Inc. and NAL Pharmaceuticals Ltd., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Herpes Zoste Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Herpes Zoste Drug Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Pcs)
Global Herpes Zoste Drug Market Segment Percentages, by Type, 2022 (%)
Acyclovir
Amenamevir
FV-100
GLS-5100
GSK-1437173A
NAL-3221
Others
Global Herpes Zoste Drug Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Pcs)
Global Herpes Zoste Drug Market Segment Percentages, by Application, 2022 (%)
Clinic
Hospital
Others
Global Herpes Zoste Drug Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Pcs)
Global Herpes Zoste Drug Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Herpes Zoste Drug revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Herpes Zoste Drug revenues share in global market, 2022 (%)
Key companies Herpes Zoste Drug sales in global market, 2018-2023 (Estimated), (K Pcs)
Key companies Herpes Zoste Drug sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Astellas Pharma Inc.
Beijing Minhai Biotechnology Co., Ltd
ContraVir Pharmaceuticals, Inc.
Epiphany Biosciences, Inc.
Foamix Pharmaceuticals Ltd.
GeneOne Life Science, Inc.
GlaxoSmithKline Plc
Merck & Co., Inc.
NAL Pharmaceuticals Ltd.
ReceptoPharm, Inc.
TSRL, Inc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Herpes Zoste Drug, market overview.
Chapter 2: Global Herpes Zoste Drug market size in revenue and volume.
Chapter 3: Detailed analysis of Herpes Zoste Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Herpes Zoste Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Herpes Zoste Drug capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Herpes Zoste Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Herpes Zoste Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Herpes Zoste Drug Overall Market Size
2.1 Global Herpes Zoste Drug Market Size: 2022 VS 2029
2.2 Global Herpes Zoste Drug Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Herpes Zoste Drug Sales: 2018-2029
3 Company Landscape
3.1 Top Herpes Zoste Drug Players in Global Market
3.2 Top Global Herpes Zoste Drug Companies Ranked by Revenue
3.3 Global Herpes Zoste Drug Revenue by Companies
3.4 Global Herpes Zoste Drug Sales by Companies
3.5 Global Herpes Zoste Drug Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Herpes Zoste Drug Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Herpes Zoste Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Herpes Zoste Drug Players in Global Market
3.8.1 List of Global Tier 1 Herpes Zoste Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Herpes Zoste Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Herpes Zoste Drug Market Size Markets, 2022 & 2029
4.1.2 Acyclovir
4.1.3 Amenamevir
4.1.4 FV-100
4.1.5 GLS-5100
4.1.6 GSK-1437173A
4.1.7 NAL-3221
4.1.8 Others
4.2 By Type – Global Herpes Zoste Drug Revenue & Forecasts
4.2.1 By Type – Global Herpes Zoste Drug Revenue, 2018-2023
4.2.2 By Type – Global Herpes Zoste Drug Revenue, 2024-2029
4.2.3 By Type – Global Herpes Zoste Drug Revenue Market Share, 2018-2029
4.3 By Type – Global Herpes Zoste Drug Sales & Forecasts
4.3.1 By Type – Global Herpes Zoste Drug Sales, 2018-2023
4.3.2 By Type – Global Herpes Zoste Drug Sales, 2024-2029
4.3.3 By Type – Global Herpes Zoste Drug Sales Market Share, 2018-2029
4.4 By Type – Global Herpes Zoste Drug Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Herpes Zoste Drug Market Size, 2022 & 2029
5.1.2 Clinic
5.1.3 Hospital
5.1.4 Others
5.2 By Application – Global Herpes Zoste Drug Revenue & Forecasts
5.2.1 By Application – Global Herpes Zoste Drug Revenue, 2018-2023
5.2.2 By Application – Global Herpes Zoste Drug Revenue, 2024-2029
5.2.3 By Application – Global Herpes Zoste Drug Revenue Market Share, 2018-2029
5.3 By Application – Global Herpes Zoste Drug Sales & Forecasts
5.3.1 By Application – Global Herpes Zoste Drug Sales, 2018-2023
5.3.2 By Application – Global Herpes Zoste Drug Sales, 2024-2029
5.3.3 By Application – Global Herpes Zoste Drug Sales Market Share, 2018-2029
5.4 By Application – Global Herpes Zoste Drug Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Herpes Zoste Drug Market Size, 2022 & 2029
6.2 By Region – Global Herpes Zoste Drug Revenue & Forecasts
6.2.1 By Region – Global Herpes Zoste Drug Revenue, 2018-2023
6.2.2 By Region – Global Herpes Zoste Drug Revenue, 2024-2029
6.2.3 By Region – Global Herpes Zoste Drug Revenue Market Share, 2018-2029
6.3 By Region – Global Herpes Zoste Drug Sales & Forecasts
6.3.1 By Region – Global Herpes Zoste Drug Sales, 2018-2023
6.3.2 By Region – Global Herpes Zoste Drug Sales, 2024-2029
6.3.3 By Region – Global Herpes Zoste Drug Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Herpes Zoste Drug Revenue, 2018-2029
6.4.2 By Country – North America Herpes Zoste Drug Sales, 2018-2029
6.4.3 US Herpes Zoste Drug Market Size, 2018-2029
6.4.4 Canada Herpes Zoste Drug Market Size, 2018-2029
6.4.5 Mexico Herpes Zoste Drug Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Herpes Zoste Drug Revenue, 2018-2029
6.5.2 By Country – Europe Herpes Zoste Drug Sales, 2018-2029
6.5.3 Germany Herpes Zoste Drug Market Size, 2018-2029
6.5.4 France Herpes Zoste Drug Market Size, 2018-2029
6.5.5 U.K. Herpes Zoste Drug Market Size, 2018-2029
6.5.6 Italy Herpes Zoste Drug Market Size, 2018-2029
6.5.7 Russia Herpes Zoste Drug Market Size, 2018-2029
6.5.8 Nordic Countries Herpes Zoste Drug Market Size, 2018-2029
6.5.9 Benelux Herpes Zoste Drug Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Herpes Zoste Drug Revenue, 2018-2029
6.6.2 By Region – Asia Herpes Zoste Drug Sales, 2018-2029
6.6.3 China Herpes Zoste Drug Market Size, 2018-2029
6.6.4 Japan Herpes Zoste Drug Market Size, 2018-2029
6.6.5 South Korea Herpes Zoste Drug Market Size, 2018-2029
6.6.6 Southeast Asia Herpes Zoste Drug Market Size, 2018-2029
6.6.7 India Herpes Zoste Drug Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Herpes Zoste Drug Revenue, 2018-2029
6.7.2 By Country – South America Herpes Zoste Drug Sales, 2018-2029
6.7.3 Brazil Herpes Zoste Drug Market Size, 2018-2029
6.7.4 Argentina Herpes Zoste Drug Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Herpes Zoste Drug Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Herpes Zoste Drug Sales, 2018-2029
6.8.3 Turkey Herpes Zoste Drug Market Size, 2018-2029
6.8.4 Israel Herpes Zoste Drug Market Size, 2018-2029
6.8.5 Saudi Arabia Herpes Zoste Drug Market Size, 2018-2029
6.8.6 UAE Herpes Zoste Drug Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Astellas Pharma Inc.
7.1.1 Astellas Pharma Inc. Company Summary
7.1.2 Astellas Pharma Inc. Business Overview
7.1.3 Astellas Pharma Inc. Herpes Zoste Drug Major Product Offerings
7.1.4 Astellas Pharma Inc. Herpes Zoste Drug Sales and Revenue in Global (2018-2023)
7.1.5 Astellas Pharma Inc. Key News & Latest Developments
7.2 Beijing Minhai Biotechnology Co., Ltd
7.2.1 Beijing Minhai Biotechnology Co., Ltd Company Summary
7.2.2 Beijing Minhai Biotechnology Co., Ltd Business Overview
7.2.3 Beijing Minhai Biotechnology Co., Ltd Herpes Zoste Drug Major Product Offerings
7.2.4 Beijing Minhai Biotechnology Co., Ltd Herpes Zoste Drug Sales and Revenue in Global (2018-2023)
7.2.5 Beijing Minhai Biotechnology Co., Ltd Key News & Latest Developments
7.3 ContraVir Pharmaceuticals, Inc.
7.3.1 ContraVir Pharmaceuticals, Inc. Company Summary
7.3.2 ContraVir Pharmaceuticals, Inc. Business Overview
7.3.3 ContraVir Pharmaceuticals, Inc. Herpes Zoste Drug Major Product Offerings
7.3.4 ContraVir Pharmaceuticals, Inc. Herpes Zoste Drug Sales and Revenue in Global (2018-2023)
7.3.5 ContraVir Pharmaceuticals, Inc. Key News & Latest Developments
7.4 Epiphany Biosciences, Inc.
7.4.1 Epiphany Biosciences, Inc. Company Summary
7.4.2 Epiphany Biosciences, Inc. Business Overview
7.4.3 Epiphany Biosciences, Inc. Herpes Zoste Drug Major Product Offerings
7.4.4 Epiphany Biosciences, Inc. Herpes Zoste Drug Sales and Revenue in Global (2018-2023)
7.4.5 Epiphany Biosciences, Inc. Key News & Latest Developments
7.5 Foamix Pharmaceuticals Ltd.
7.5.1 Foamix Pharmaceuticals Ltd. Company Summary
7.5.2 Foamix Pharmaceuticals Ltd. Business Overview
7.5.3 Foamix Pharmaceuticals Ltd. Herpes Zoste Drug Major Product Offerings
7.5.4 Foamix Pharmaceuticals Ltd. Herpes Zoste Drug Sales and Revenue in Global (2018-2023)
7.5.5 Foamix Pharmaceuticals Ltd. Key News & Latest Developments
7.6 GeneOne Life Science, Inc.
7.6.1 GeneOne Life Science, Inc. Company Summary
7.6.2 GeneOne Life Science, Inc. Business Overview
7.6.3 GeneOne Life Science, Inc. Herpes Zoste Drug Major Product Offerings
7.6.4 GeneOne Life Science, Inc. Herpes Zoste Drug Sales and Revenue in Global (2018-2023)
7.6.5 GeneOne Life Science, Inc. Key News & Latest Developments
7.7 GlaxoSmithKline Plc
7.7.1 GlaxoSmithKline Plc Company Summary
7.7.2 GlaxoSmithKline Plc Business Overview
7.7.3 GlaxoSmithKline Plc Herpes Zoste Drug Major Product Offerings
7.7.4 GlaxoSmithKline Plc Herpes Zoste Drug Sales and Revenue in Global (2018-2023)
7.7.5 GlaxoSmithKline Plc Key News & Latest Developments
7.8 Merck & Co., Inc.
7.8.1 Merck & Co., Inc. Company Summary
7.8.2 Merck & Co., Inc. Business Overview
7.8.3 Merck & Co., Inc. Herpes Zoste Drug Major Product Offerings
7.8.4 Merck & Co., Inc. Herpes Zoste Drug Sales and Revenue in Global (2018-2023)
7.8.5 Merck & Co., Inc. Key News & Latest Developments
7.9 NAL Pharmaceuticals Ltd.
7.9.1 NAL Pharmaceuticals Ltd. Company Summary
7.9.2 NAL Pharmaceuticals Ltd. Business Overview
7.9.3 NAL Pharmaceuticals Ltd. Herpes Zoste Drug Major Product Offerings
7.9.4 NAL Pharmaceuticals Ltd. Herpes Zoste Drug Sales and Revenue in Global (2018-2023)
7.9.5 NAL Pharmaceuticals Ltd. Key News & Latest Developments
7.10 ReceptoPharm, Inc.
7.10.1 ReceptoPharm, Inc. Company Summary
7.10.2 ReceptoPharm, Inc. Business Overview
7.10.3 ReceptoPharm, Inc. Herpes Zoste Drug Major Product Offerings
7.10.4 ReceptoPharm, Inc. Herpes Zoste Drug Sales and Revenue in Global (2018-2023)
7.10.5 ReceptoPharm, Inc. Key News & Latest Developments
7.11 TSRL, Inc.
7.11.1 TSRL, Inc. Company Summary
7.11.2 TSRL, Inc. Herpes Zoste Drug Business Overview
7.11.3 TSRL, Inc. Herpes Zoste Drug Major Product Offerings
7.11.4 TSRL, Inc. Herpes Zoste Drug Sales and Revenue in Global (2018-2023)
7.11.5 TSRL, Inc. Key News & Latest Developments
8 Global Herpes Zoste Drug Production Capacity, Analysis
8.1 Global Herpes Zoste Drug Production Capacity, 2018-2029
8.2 Herpes Zoste Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Herpes Zoste Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Herpes Zoste Drug Supply Chain Analysis
10.1 Herpes Zoste Drug Industry Value Chain
10.2 Herpes Zoste Drug Upstream Market
10.3 Herpes Zoste Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Herpes Zoste Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Herpes Zoste Drug in Global Market
Table 2. Top Herpes Zoste Drug Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Herpes Zoste Drug Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Herpes Zoste Drug Revenue Share by Companies, 2018-2023
Table 5. Global Herpes Zoste Drug Sales by Companies, (K Pcs), 2018-2023
Table 6. Global Herpes Zoste Drug Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Herpes Zoste Drug Price (2018-2023) & (USD/Pcs)
Table 8. Global Manufacturers Herpes Zoste Drug Product Type
Table 9. List of Global Tier 1 Herpes Zoste Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Herpes Zoste Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Herpes Zoste Drug Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Herpes Zoste Drug Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Herpes Zoste Drug Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Herpes Zoste Drug Sales (K Pcs), 2018-2023
Table 15. By Type - Global Herpes Zoste Drug Sales (K Pcs), 2024-2029
Table 16. By Application – Global Herpes Zoste Drug Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Herpes Zoste Drug Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Herpes Zoste Drug Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Herpes Zoste Drug Sales (K Pcs), 2018-2023
Table 20. By Application - Global Herpes Zoste Drug Sales (K Pcs), 2024-2029
Table 21. By Region – Global Herpes Zoste Drug Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Herpes Zoste Drug Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Herpes Zoste Drug Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Herpes Zoste Drug Sales (K Pcs), 2018-2023
Table 25. By Region - Global Herpes Zoste Drug Sales (K Pcs), 2024-2029
Table 26. By Country - North America Herpes Zoste Drug Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Herpes Zoste Drug Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Herpes Zoste Drug Sales, (K Pcs), 2018-2023
Table 29. By Country - North America Herpes Zoste Drug Sales, (K Pcs), 2024-2029
Table 30. By Country - Europe Herpes Zoste Drug Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Herpes Zoste Drug Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Herpes Zoste Drug Sales, (K Pcs), 2018-2023
Table 33. By Country - Europe Herpes Zoste Drug Sales, (K Pcs), 2024-2029
Table 34. By Region - Asia Herpes Zoste Drug Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Herpes Zoste Drug Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Herpes Zoste Drug Sales, (K Pcs), 2018-2023
Table 37. By Region - Asia Herpes Zoste Drug Sales, (K Pcs), 2024-2029
Table 38. By Country - South America Herpes Zoste Drug Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Herpes Zoste Drug Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Herpes Zoste Drug Sales, (K Pcs), 2018-2023
Table 41. By Country - South America Herpes Zoste Drug Sales, (K Pcs), 2024-2029
Table 42. By Country - Middle East & Africa Herpes Zoste Drug Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Herpes Zoste Drug Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Herpes Zoste Drug Sales, (K Pcs), 2018-2023
Table 45. By Country - Middle East & Africa Herpes Zoste Drug Sales, (K Pcs), 2024-2029
Table 46. Astellas Pharma Inc. Company Summary
Table 47. Astellas Pharma Inc. Herpes Zoste Drug Product Offerings
Table 48. Astellas Pharma Inc. Herpes Zoste Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 49. Astellas Pharma Inc. Key News & Latest Developments
Table 50. Beijing Minhai Biotechnology Co., Ltd Company Summary
Table 51. Beijing Minhai Biotechnology Co., Ltd Herpes Zoste Drug Product Offerings
Table 52. Beijing Minhai Biotechnology Co., Ltd Herpes Zoste Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 53. Beijing Minhai Biotechnology Co., Ltd Key News & Latest Developments
Table 54. ContraVir Pharmaceuticals, Inc. Company Summary
Table 55. ContraVir Pharmaceuticals, Inc. Herpes Zoste Drug Product Offerings
Table 56. ContraVir Pharmaceuticals, Inc. Herpes Zoste Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 57. ContraVir Pharmaceuticals, Inc. Key News & Latest Developments
Table 58. Epiphany Biosciences, Inc. Company Summary
Table 59. Epiphany Biosciences, Inc. Herpes Zoste Drug Product Offerings
Table 60. Epiphany Biosciences, Inc. Herpes Zoste Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 61. Epiphany Biosciences, Inc. Key News & Latest Developments
Table 62. Foamix Pharmaceuticals Ltd. Company Summary
Table 63. Foamix Pharmaceuticals Ltd. Herpes Zoste Drug Product Offerings
Table 64. Foamix Pharmaceuticals Ltd. Herpes Zoste Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 65. Foamix Pharmaceuticals Ltd. Key News & Latest Developments
Table 66. GeneOne Life Science, Inc. Company Summary
Table 67. GeneOne Life Science, Inc. Herpes Zoste Drug Product Offerings
Table 68. GeneOne Life Science, Inc. Herpes Zoste Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 69. GeneOne Life Science, Inc. Key News & Latest Developments
Table 70. GlaxoSmithKline Plc Company Summary
Table 71. GlaxoSmithKline Plc Herpes Zoste Drug Product Offerings
Table 72. GlaxoSmithKline Plc Herpes Zoste Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 73. GlaxoSmithKline Plc Key News & Latest Developments
Table 74. Merck & Co., Inc. Company Summary
Table 75. Merck & Co., Inc. Herpes Zoste Drug Product Offerings
Table 76. Merck & Co., Inc. Herpes Zoste Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 77. Merck & Co., Inc. Key News & Latest Developments
Table 78. NAL Pharmaceuticals Ltd. Company Summary
Table 79. NAL Pharmaceuticals Ltd. Herpes Zoste Drug Product Offerings
Table 80. NAL Pharmaceuticals Ltd. Herpes Zoste Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 81. NAL Pharmaceuticals Ltd. Key News & Latest Developments
Table 82. ReceptoPharm, Inc. Company Summary
Table 83. ReceptoPharm, Inc. Herpes Zoste Drug Product Offerings
Table 84. ReceptoPharm, Inc. Herpes Zoste Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 85. ReceptoPharm, Inc. Key News & Latest Developments
Table 86. TSRL, Inc. Company Summary
Table 87. TSRL, Inc. Herpes Zoste Drug Product Offerings
Table 88. TSRL, Inc. Herpes Zoste Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 89. TSRL, Inc. Key News & Latest Developments
Table 90. Herpes Zoste Drug Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2021-2023 (K Pcs)
Table 91. Global Herpes Zoste Drug Capacity Market Share of Key Manufacturers, 2021-2023
Table 92. Global Herpes Zoste Drug Production by Region, 2018-2023 (K Pcs)
Table 93. Global Herpes Zoste Drug Production by Region, 2024-2029 (K Pcs)
Table 94. Herpes Zoste Drug Market Opportunities & Trends in Global Market
Table 95. Herpes Zoste Drug Market Drivers in Global Market
Table 96. Herpes Zoste Drug Market Restraints in Global Market
Table 97. Herpes Zoste Drug Raw Materials
Table 98. Herpes Zoste Drug Raw Materials Suppliers in Global Market
Table 99. Typical Herpes Zoste Drug Downstream
Table 100. Herpes Zoste Drug Downstream Clients in Global Market
Table 101. Herpes Zoste Drug Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Herpes Zoste Drug Segment by Type in 2022
Figure 2. Herpes Zoste Drug Segment by Application in 2022
Figure 3. Global Herpes Zoste Drug Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Herpes Zoste Drug Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Herpes Zoste Drug Revenue, 2018-2029 (US$, Mn)
Figure 7. Herpes Zoste Drug Sales in Global Market: 2018-2029 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Herpes Zoste Drug Revenue in 2022
Figure 9. By Type - Global Herpes Zoste Drug Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Herpes Zoste Drug Revenue Market Share, 2018-2029
Figure 11. By Type - Global Herpes Zoste Drug Sales Market Share, 2018-2029
Figure 12. By Type - Global Herpes Zoste Drug Price (USD/Pcs), 2018-2029
Figure 13. By Application - Global Herpes Zoste Drug Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Herpes Zoste Drug Revenue Market Share, 2018-2029
Figure 15. By Application - Global Herpes Zoste Drug Sales Market Share, 2018-2029
Figure 16. By Application - Global Herpes Zoste Drug Price (USD/Pcs), 2018-2029
Figure 17. By Region - Global Herpes Zoste Drug Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Herpes Zoste Drug Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Herpes Zoste Drug Revenue Market Share, 2018-2029
Figure 20. By Region - Global Herpes Zoste Drug Sales Market Share, 2018-2029
Figure 21. By Country - North America Herpes Zoste Drug Revenue Market Share, 2018-2029
Figure 22. By Country - North America Herpes Zoste Drug Sales Market Share, 2018-2029
Figure 23. US Herpes Zoste Drug Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Herpes Zoste Drug Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Herpes Zoste Drug Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Herpes Zoste Drug Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Herpes Zoste Drug Sales Market Share, 2018-2029
Figure 28. Germany Herpes Zoste Drug Revenue, (US$, Mn), 2018-2029
Figure 29. France Herpes Zoste Drug Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Herpes Zoste Drug Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Herpes Zoste Drug Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Herpes Zoste Drug Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Herpes Zoste Drug Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Herpes Zoste Drug Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Herpes Zoste Drug Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Herpes Zoste Drug Sales Market Share, 2018-2029
Figure 37. China Herpes Zoste Drug Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Herpes Zoste Drug Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Herpes Zoste Drug Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Herpes Zoste Drug Revenue, (US$, Mn), 2018-2029
Figure 41. India Herpes Zoste Drug Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Herpes Zoste Drug Revenue Market Share, 2018-2029
Figure 43. By Country - South America Herpes Zoste Drug Sales Market Share, 2018-2029
Figure 44. Brazil Herpes Zoste Drug Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Herpes Zoste Drug Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Herpes Zoste Drug Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Herpes Zoste Drug Sales Market Share, 2018-2029
Figure 48. Turkey Herpes Zoste Drug Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Herpes Zoste Drug Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Herpes Zoste Drug Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Herpes Zoste Drug Revenue, (US$, Mn), 2018-2029
Figure 52. Global Herpes Zoste Drug Production Capacity (K Pcs), 2018-2029
Figure 53. The Percentage of Production Herpes Zoste Drug by Region, 2022 VS 2029
Figure 54. Herpes Zoste Drug Industry Value Chain
Figure 55. Marketing Channels


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 帯状疱疹治療薬の世界市場見通し2023年-2029年(Herpes Zoste Drug Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 単純ヘルペスウイルス治療の世界市場2021-2031：機会分析・産業予測

    • ◆H&Iグローバルリサーチのお客様（例）◆